For millennia, cultures around the world have embraced mind-altering substances to catalyze healing. Western psychotherapy has generally resisted the healing potential of such substances, but the FDA has lately approved clinical trials using MDMA—also known as Ecstasy, or Molly—to treat PTSD. Psychotherapists have a major role to play in these treatments, by helping clients process the healing shifts in consciousness that can occur on the drug.
Continuing Professional Development Certificates
- PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 3 hours CPD.
Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.
Financial: Michael Mithoefer receives a salary and grants from MAPS Public Benefit Corp and is a clinical assistant professor at the Medical University of South Carolina.
Non-financial: Michael Mithoefer is a member of the non-profit MAPS.
Access for Self-Study (Non-Interactive)
Access never expires for this product.
Explore specifics of the role therapists play in the healing process of MDMA-assisted psychotherapy, including balancing a non-directive approach with interventions based on the therapist’s training and intuition.
Explore what typically happens in the eight-hour therapy sessions that accompany the administering of MDMA.
Explore the history of MDMA and how its pharmacologic profile makes it effective against treatment resistant PTSD.
Identify the research processes used to determine the efficacy of MDMA and analyze the clinical impact on patients and quality of life after MDMA Assisted Psychotherapy in order to improve clinical outcomes with Post Traumatic Stress Disorder.
History of MDMA
MDMA as Psychedelic
MDMA Therapy Use in the 1970’s and 1980’s
Clinical Trials & Results
Study with Veterans, Firefighters, & Police Officers
Additional Participant CE must be purchased for each additional viewer. These viewers will watch the video with the main registrant, but will have individual access to course handouts and certification. The standard price of this program includes certification for main viewer.